Table 3.
Random Effects Model for Caregiver Depressive Symptomatologya (n = 237)
Coefficient | Significance | 95% Confidence Interval | |
---|---|---|---|
Caregiver age | −0.141 | 0.000 | −0.210, −0.072 |
Caregiver sex | 0.239 | 0.792 | −1.536, 2.014 |
Caregiver comorbidity | 0.695 | 0.037 | 0.041, 1.349 |
Patient comorbidity | −0.157 | 0.589 | −0.727, 0.413 |
Intervention (1 = experimental, 2 = control) | −1.607 | 0.057 | −3.263, 0.049 |
Mastery | −0.615 | 0.000 | −0.809, −0.422 |
Symptom assistance | 0.400 | 0.033 | 0.033, 0.768 |
Caregiver social functioning | −0.177 | 0.000 | −0.215, −0.139 |
Stage of disease (1 = early, 2 = late) | 2.315 | 0.021 | 0.343, 4.288 |
Cancer site | |||
Lung versus breast | 1.352 | 0.250 | −0.953, 3.656 |
Other versus breast | −0.577 | 0.626 | −2.900, 1.746 |
Patient depressive symptomatology | 0.097 | 0.090 | −0.015, 0.210 |
Patient symptom severity | −0.081 | 0.008 | −0.141, −0.021 |
Patient physical functioning | −0.015 | 0.449 | −0.055, 0.024 |
Patient social functioning | 0.005 | 0.781 | −0.032, 0.043 |
Chemotherapy status | 2.171 | 0.129 | −0.629, 4.970 |
Time | 0.583 | 0.428 | −0.858, 2.023 |
Number of person-interview observations 339; observations per case: maximum 3, minimum 1, average 1.7; R2-within 0.4792, R2-between 0.4312, R2-overall 0.4506.